Patient ID,Sample ID,Cancer Study,Cancer Type,Cancer Type Detailed,Number of Samples Per Patient,Mutation Count,Fraction Genome Altered,Sex,Ethnicity Category,Sample Type,Age at Which Sequencing was Reported,Center,Oncotree Code,Primary Race,Sample Type Detailed,Sequence Assay ID
GENIE-MSK-P-0024165,GENIE-MSK-P-0024165-T01-IM6,genie_public,Bone Cancer,Adamantinoma,1,1,0.3804,Female,Non-Spanish/non-Hispanic,Primary,79,MSK,ADMA,White,Primary tumor,MSK-IMPACT468
GENIE-MSK-P-0031635,GENIE-MSK-P-0031635-T01-IM6,genie_public,Bone Cancer,Adamantinoma,1,,0.0001,Male,Non-Spanish/non-Hispanic,Primary,<18,MSK,ADMA,White,Primary tumor,MSK-IMPACT468
GENIE-MSK-P-0049947,GENIE-MSK-P-0049947-T01-IM6,genie_public,Bone Cancer,Adamantinoma,1,,0.0508,Male,Non-Spanish/non-Hispanic,Primary,<18,MSK,ADMA,Black,Primary tumor,MSK-IMPACT468